In the past week, InSysBio announced an extension of its collaboration with BeOne Medicines, applying mechanistic translational modeling to refine starting doses, step-up regimens, and dose-escalation ...
ONC, extended its collaboration with InSysBio to apply mechanistic translational modeling to clinical trial design. The expanded partnership focuses on refining dosing regimens and addressing safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results